3250 ex2 My Notes
Dermatological Malignancies and Neoplasms
Basal Cell Carcinoma (BCC):
- Epidemiology & Prevalence:
- Most common type of skin cancer.
- Most frequently situated on sun-exposed anatomical sites, with the top of the ear being the most common location, alongside the face, nose, hands, and scalp.
- Pathophysiology & Origin:
- Originates from the basal layer of the epidermis and hair follicles.
- Ultraviolet (UV) radiation is the primary causative etiology.
- Characterized as a slow-growing neoplasm that rarely metastasizes to distant structures.
- Clinical Presentation:
- Classic morphologic appearance: Pearly, translucent, waxy dome-shaped papule featuring raised, rolled borders.
- Features a central ulceration that bleeds easily with minimal trauma, historically referred to as a "rodent ulcer."
- Lesions are predominantly painless.
- Risk Factors:
- High risk: History of severe sunburns.
- UV exposure via outdoor sun exposure or tanning beds.
- Phenotypic risk factors: Fair skin, red or blond hair.
- Demographic risk: Males older than years of age.
- Personal history of prior skin malignancies.
- Treatment Modalities:
- Mohs micrographic surgery: Layer-by-layer excision with intraoperative frozen-section microscopic margin evaluation.
- Electrodesiccation and curettage (ED&C).
- Cryotherapy.
- Radiation therapy.
- Photodynamic therapy.
- Prevention & Client Education:
- Avoid ultraviolet exposure during peak intensity hours between and .
- Apply broad-spectrum sunscreen prior to sun exposure; reapply every and immediately following swimming.
- Undergo annual professional skin examinations by a healthcare provider after reaching years of age.
Malignant Melanoma:
- Clinical Significance: Represents the most lethal and dangerous skin malignancy.
- Morphological Characteristics:
- Lesions typically display irregular borders, asymmetric shapes, and variegated pigmentation (multiple colors including dark blue and black shades).
- ABCDE Diagnostic Criteria:
- A: Asymmetry.
- B: Border irregularity.
- C: Color variation (e.g., mixtures of brown, black, red, white, or dark blue).
- D: Diameter (typically , though can be smaller).
- E: Evolving (changes in size, shape, surface, or symptoms over time).
- Postoperative Priority: Pain control is the primary nursing action following surgical excision.
Assessment of Benign vs. Suspicious Moles (Nevi):
- Non-Cancerous (Benign) Features:
- Diameter less than .
- Symmetrical, smooth contours.
- Surface architecture: Flat (macular) or dome-shaped (papular).
- Uniform coloration: Tan, brown, or black.
- Malignancy Warning Sign: The presence of blue coloration within a mole is a primary warning sign for melanoma and warrants immediate biopsy.
Kaposi Sarcoma:
- Pathophysiology: Malignancy involving the endothelial lining of blood vessels.
- Etiology: Causally linked to Human Herpesvirus 8 (HHV-8).
- Population at Risk: Immunocompromised hosts, specifically clients diagnosed with HIV/AIDS.
- Clinical Presentation:
- Cutaneous manifestations: Flat or raised reddish-purple to dark blue vascular lesions.
- Visceral/Pulmonary involvement: Development of pulmonary lesions results in dyspnea.
- Treatment: Antiretroviral therapy (ART), which effectively shrinks the lesions by restoring immune competence.
Viral Skin and Mucosal Infections
Herpes Simplex Virus Type 1 (HSV-1):
- Etiology & Virology:
- Double-stranded DNA virus.
- Pathogen primarily responsible for cold sores (herpes labialis) and impetigo-like secondary presentations.
- Following primary infection, the virus persists indefinitely within the host (lifelong latency).
- Latency reservoir: Viral genomes reside permanently within the sensory neurons of the trigeminal nerve and its sensory ganglia.
- Transmission & Reactivation Triggers:
- Spread occurs via direct contact, including during periods of asymptomatic viral shedding.
- Trigger factors for viral reactivation: Emotional or physiological stress, sunlight exposure, hormonal fluctuations, and concurrent systemic illness.
- Progression of Lesions:
- Prodrome: Burning, tingling, or paresthesias occurring up to prior to lesion emergence.
- Initial lesions: Umbilicated vesicles on an erythematous base (classically described as "dew drops on a rose petal").
- Lesion evolution: Vesicles transition into pustules, which rupture into exquisitely painful ulcers, subsequently crusting over into honey-colored crusted plates.
- Resolution: Spontaneous healing takes , with complete resolution occurring within .
- Complications & Anatomical Variants:
- Herpetic whitlow: Painful HSV infection localized to the digits of the hand.
- Ocular involvement: Can lead directly to corneal scarring and permanent vision loss.
- Life-threatening complications: HSV encephalitis (central nervous system infection) and Eczema herpeticum (widespread cutaneous dissemination across underlying atopic skin).
- Diagnostics & Pharmacotherapy:
- Diagnostic confirmation: Tzanck smear showing multinucleated giant cells.
- Antiviral therapeutics: Acyclovir, Valacyclovir, or Famciclovir.
- Therapeutic window: Antivirals must be initiated within of lesion onset and administered for a duration of .
- Client teaching: Strict avoidance of physical or sexual contact during prodromal tingling and active weeping phases.
Herpes Simplex Virus Type 2 (HSV-2):
- Transmission & Pathophysiology:
- Transmitted primarily via sexual contact; perinatal transmission also occurs during vaginal delivery.
- Primary viral etiology of genital herpes.
- Establishes permanent latent infection within the lumbosacral sensory root ganglia.
- Clinical course is unpredictable; the majority of disease transmission occurs via asymptomatic viral shedding.
- Clinical Presentation:
- Painful clusters of vesicles distributed over the penis, vulva, perineum, or cervix.
- Active episodes persist for .
- Accompanying systemic symptoms: Regional lymphadenopathy (enlarged lymph nodes) and severe dysuria.
- Diagnostic Testing: Tzanck smear.
- Pharmacological Management: Systemic oral antivirals including Acyclovir, Valacyclovir, and Famciclovir.
- Nursing Interventions & Symptom Relief:
- To relieve excruciating dysuria, instruct the client to pour warm water over the vulva while voiding.
- Monitor closely for urinary retention secondary to perineal pain and urethral inflammation.
- Utilize warm sitz baths, administer acetaminophen for analgesia, and aggressively increase oral fluid intake.
- Emergency & Adverse Reactions:
- First action for systemic anaphylaxis: Administer Epinephrine via intramuscular (IM) injection.
- Stevens-Johnson syndrome (SJS): Severe, potentially fatal drug reaction characterized by extensive epidermal detachment, blistering, and skin peeling.
Herpes Zoster (Shingles):
- Pathophysiology & Disease Progression:
- Caused by the reactivation of the latent Varicella-Zoster Virus (VZV) that initially caused primary chickenpox.
- Dormant state resides within the dorsal cranial nerve ganglia or spinal sensory nerve roots.
- Characterized by unilateral dermatomal distribution (strictly confined to one side of the body following a single nerve pathway).
- Reactivates down the sensory nerve fiber; the majority of immunocompetent individuals experience only a single lifetime episode.
- Epidemiology:
- Highest risk group: Elderly individuals and immunocompromised clients.
- Lifetime risk: individuals in the United States; recurrence rate is low ().
- Clinical Manifestations:
- Prodromal phase: Intense localized itching, burning, and dysesthesia developing before cutaneous eruption.
- Classic eruption: Grouped, clear vesicles situated on an erythematous base arranged in a discrete dermatomal band (e.g., across the right unilateral chest wall).
- Vesicles develop over ; total rash duration ranges from weeks to months accompanied by severe neuropathic pain.
- Complications:
- Hutchinson sign: Presence of zoster vesicles on the tip or side of the nose, indicating involvement of the ophthalmic branch of the trigeminal nerve; carries an extreme risk of corneal ulceration and permanent blindness.
- Facial nerve involvement: Can result in facial muscle paralysis.
- Postherpetic Neuralgia (PHN): The single most common chronic complication in individuals over years of age, characterized by unrelenting neuropathic pain persisting long after the cutaneous rash has fully healed.
- Diagnostics & Medical Interventions:
- Diagnosis: Clinical recognition of unilateral dermatomal lesions, confirmed via VZV polymerase chain reaction (PCR) swab or Tzanck smear.
- Pharmacotherapy: Famciclovir, Acyclovir, or Valacyclovir; administration must be initiated within of rash appearance to minimize severity and prevent PHN.
- Immunization: Shingrix recombinant zoster vaccine is formally recommended for all adults aged years and older.
- Transmission-Based Precautions:
- Disseminated Zoster (widespread lesions extending beyond two dermatomes): Strict Airborne and Contact Precautions (negative-pressure isolation room with door closed, use of an N95 respirator, gown, and gloves).
- Localized Zoster (healthy host, intact immunity): Standard plus Contact Precautions, ensuring all draining lesions remain completely covered.
Comparative Virology: Herpes Zoster vs. Herpes Simplex:
- Herpes Zoster: Travels down a single sensory nerve fiber along a specific dermatome; most clients experience only one lifetime episode.
- Herpes Simplex: Reactivates repeatedly at the exact same anatomical mucocutaneous site multiple times per year.
Chronic Inflammatory and Autoimmune Skin Disorders
Atopic Dermatitis (Eczema):
- Pathophysiology: Chronic, endogenous inflammatory dermatosis characterized by marked elevation of serum Immunoglobulin E ().
- Atopic Triad: Strong genetic and clinical correlation with Asthma and Allergic Rhinitis.
- Environmental & Dietary Triggers:
- Foods: Cow's milk/dairy, eggs, soy, wheat, and peanuts.
- Inhalants & Contactants: Dust mites, environmental molds, animal dander, wool fibers, and synthetic fabrics.
- Clinical Manifestations: Intensely pruritic, erythematous, dry patches with weeping, crusting, or lichenified excoriations.
- Nursing Care & Client Education:
- Hydration: Apply emollient moisturizers immediately following bathing to seal in skin hydration.
- Bathing precautions: Avoid continuous handwashing with harsh antibacterial soaps, as they strip lipid barriers and exacerbate severe xerosis.
- Environmental management: Use cool-mist room humidifiers and apply soothing calamine lotion.
- Clothing: Wear loose-fitting, soft cotton clothing to minimize cutaneous friction and pruritus.
Contact Dermatitis:
- Pathophysiology: Exogenous inflammatory reaction resulting from contact with external allergens or chemical irritants.
- Clinical Features: Red, intensely pruritic, and painful vesicular eruptions; condition is non-contagious.
- Clinical Management Protocol:
- Priority intervention (Number treatment): Promptly identify and completely eliminate the offending causative agent.
- Topical therapy: Apply topical corticosteroids to suppress local immune-mediated inflammation.
- Weeping lesions: Apply cool, wet therapeutic compresses to open, weeping vesicles.
- Hygiene instructions: Absolutely avoid vigorous scrubbing or mechanical exfoliation; the belief that scrubbing during bathing prevents secondary infection is entirely false and damages fragile re-epithelializing skin.
- Precautions note: Recorded isolation parameters specify Airborne Precautions (N95 respirator and negative-pressure room) within specific isolation classification frameworks for vesicular eruptions.
Pruritus Management:
- Administer systemic antihistamines and topical antipruritics.
- Pharmacology safety alert: Always assess for drug allergies prior to prescribing antimicrobials for secondary skin infections; clients with a confirmed penicillin allergy can experience cross-reactivity with cephalosporin antibiotics.
Psoriasis:
- Pathophysiology: Chronic, non-contagious autoimmune dermatosis characterized by accelerated epidermal turnover.
- Clinical Appearance: Sharply demarcated, erythematous, inflamed plaques covered by thick, silvery-white micaceous scales that bleed easily.
- Auspitz Sign: Punctate bleeding spots that appear when silvery scales are mechanically scraped or peeled away from the underlying plaque.
- Medication Contraindications & Triggers:
- Systemic (oral) corticosteroids are strictly contraindicated for psoriasis, as discontinuation reliably precipitates severe, life-threatening rebound flare-ups or generalized pustular psoriasis.
- Pharmacologic triggers: Beta-blockers can induce disease flares.
- Nursing Care & Hygiene:
- Cleanse skin daily using warm water and a soft-bristled brush to gently remove desquamating scales.
- Reassure the client and family that the condition is strictly autoimmune and non-contagious; bleaching of bed linens is not indicated.
- Promote stress management and healthy lifestyle modifications to minimize flare triggers.
- Pharmacological Interventions & Adverse Effects:
- Systemic biologicals and immunosuppressants: Infliximab infusions or oral Methotrexate.
- Safety priority for immunosuppressants: Instruct clients to immediately report fever, chills, sore throat, or active signs of infection.
- Topical medication precautions:
- Applying topical corticosteroid ointments near the ocular region can induce glaucoma or cataracts.
- Chronic overuse of potent topical steroid ointments produces permanent cutaneous atrophy, telangiectasias, and striae.
Methotrexate Pharmacology:
- Mechanism: Antimetabolite immunosuppressive agent utilized in severe, recalcitrant psoriasis and rheumatoid disease.
- Black Box Toxicities:
- Bone marrow suppression (myelosuppression leading to leukopenia, anemia, and thrombocytopenia).
- Severe hepatotoxicity leading to liver cirrhosis.
- Monitoring & Alerts:
- Routine monitoring: Serial complete blood count (CBC) and hepatic function tests (liver enzymes).
- Client reporting: Promptly report any newly developed fever, sore throat, or signs of systemic infection.
Bacterial, Fungal, Parasitic, and Vector-Borne Dermatologic Conditions
Cellulitis:
- Pathophysiology: Acute bacterial infection spreading through the deep dermis and subcutaneous tissues, most commonly caused by Staphylococcus or Streptococcus species entering through a cutaneous barrier break.
- Underlying Risk Factors: Diabetes mellitus, chronic venous insufficiency, peripheral edema, obesity, intravenous (IV) drug abuse, and generalized immunosuppression.
- Clinical Presentation: Spreading, poorly demarcated erythema, localized edema, intense pain, and marked warmth to touch.
- Nursing Interventions & Therapeutics:
- Elevate the affected limb above the level of the heart to facilitate venous and lymphatic return and minimize tissue edema.
- Apply warm, moist compresses to localize the infection and promote circulation, or utilize cool moist packs to alleviate acute discomfort.
- Antimicrobial therapy: Oral antibiotics for mild localized cases; intravenous antibiotics for severe manifestations or systemic symptoms.
Impetigo:
- Etiology: Superficial, highly contagious bacterial skin infection caused by Staphylococcus aureus or Streptococcus pyogenes.
- Infection Control: Contact Precautions (gown and gloves required).
- Clinical Features: Fragile vesicles and pustules that rupture to yield copious exudate drying into classic thick, golden, yellow honey-colored crusts.
- Management Guidelines:
- Wash affected crusted areas gently with antibacterial soap; never apply antifungal creams as they are ineffective against bacterial agents.
- Children may safely return to school after initiating effective antibiotic therapy.
- Antibiotic Therapies:
- Topical Mupirocin: Indicated for small, localized lesions.
- Oral Amoxicillin: Administered for widespread, systemic presentations.
- Oral Clindamycin: Utilized when Methicillin-Resistant Staphylococcus aureus (MRSA) is suspected or confirmed.
- Systemic Complication: Infection caused by group A beta-hemolytic Streptococcus can cause post-streptococcal glomerulonephritis; continuously monitor the client for dark (tea-colored) urine, facial/periorbital edema, and hypertension.
Methicillin-Resistant Staphylococcus aureus (MRSA) Wounds:
- Transmission Precautions: Contact Precautions.
- Classifications:
- Hospital-Acquired MRSA (HA-MRSA): Acquired secondary to invasive procedures, vascular catheters, or surgical incisions.
- Community-Acquired MRSA (CA-MRSA): Outbreaks occur in congregate settings including schools, sports teams, and correctional facilities.
- Resistance: Resistant to beta-lactams and first-generation cephalosporins (such as Cephalexin).
- Clinical Nursing Protocols:
- Always obtain appropriate wound cultures prior to administering the initial dose of prescribed antibiotics.
- Keep draining wounds securely covered; clients must not participate in contact sports until wounds are completely closed and healed.
- Household hygiene: The client and spouse should sleep in separate beds until the infection is resolved; launder clothing and linens in hot water after every body contact.
- Wound cleansing solutions: Irrigate wounds using sterile Normal Saline (); explicitly avoid harsh, cytotoxic antiseptics including hydrogen peroxide, Dakin's solution, or chlorhexidine within open wound beds.
Pediculosis (Lice Infestation):
- Clinical Management:
- First-line pediculicides: Permethrin lotion or Pyrethrins.
- Alternative/Refractory treatments: Ivermectin.
- Mechanical nit removal: Utilize a fine-toothed nit comb soaked in a vinegar solution to dissolve the chitinous glue anchoring nits to hair shafts.
- Environmental decontamination: Wash all clothing, bedding, and towels in hot water and dry on high heat; items that cannot be washed must be sealed in airtight plastic bags for .
- Isolation parameters: Maintain Contact Precautions until the first pediculicidal treatment is fully completed.
Scabies Infestation:
- Pathophysiology: Infestation by the microscopic mite Sarcoptes scabiei, which burrows into the outer epidermal layers to deposit eggs and feces.
- Transmission Precautions: Contact Precautions.
- Treatment: Application of topical Permethrin cream to the entire body from the neck down, left on for several hours before washing off.
Vaginal Yeast Infection (Candidiasis):
- Etiology: Overgrowth of opportunistic Candida albicans fungal flora within the vaginal mucosa.
- Predisposing Risk Factors:
- Broad-spectrum antibiotic therapy (depletes normal protective Lactobacillus flora).
- Uncontrolled diabetes mellitus (elevated tissue and urinary glucose fuels fungal replication).
- Systemic corticosteroid therapy.
- Immunocompromised states (HIV infection).
- Pregnancy, oral contraceptive usage, obesity, and tight, non-breathable synthetic undergarments.
- Any biological state resulting in systemic estrogen or hormonal fluctuations.
- Pharmacological Treatment: Antifungal agents including oral Fluconazole or topical/intravaginal Miconazole.
- Client Education & Long-Term Alerts:
- Wear loose-fitting, breathable cotton underwear.
- Strictly avoid vaginal douching and scented hygiene sprays.
- Complete the full course of prescribed antifungal medications.
- Recurrence alert: If a client experiences recurrent candidiasis (), diagnostic screening for underlying diabetes mellitus and HIV is indicated.
Acne Vulgaris:
- Therapeutics: Topical retinoids including Tretinoin and Adapalene; educate clients that retinoids cause marked photosensitivity and vulnerability to severe sunburns.
- Client Teaching & Daily Regimen:
- Wash the face with a mild facial cleanser daily.
- Do not vigorously scrub the skin, as mechanical friction worsens follicular inflammation.
- Do not squeeze, pop, or manually extract comedones or pustules.
- Avoid friction-inducing apparel such as tight sports helmets or chin straps.
Lyme Disease:
- Etiology & Vector: Spirochetal infection transmitted through the bite of an infected blacklegged deer tick (Ixodes).
- Clinical Staging & Manifestations:
- Stage 1 (Early Localized): Expanding erythematous papule producing an annular "bull's-eye" rash (erythema migrans) accompanied by local itching and burning. The rash does not peak within ; instead, it emerges following the initial tick bite.
- Stage 2 (Early Disseminated): Neurological and cardiac manifestations including lymphocytic meningitis, cranial neuropathies (such as unilateral or bilateral Bell's palsy), and peripheral neuropathy.
- Stage 3 (Late Disseminated): Severe central nervous system abnormalities, cognitive deficits, and persistent, migratory inflammatory arthritis affecting large joints (especially knees); can present up to a year or more after the initial bite if untreated.
Pressure Injury Staging and Nursing Interventions
Anatomical Staging Guidelines:
- Stage 1 Pressure Injury:
- Intact skin presenting with a localized area of non-blanchable erythema.
- Blanching does not occur when pressure is applied over the bony prominence.
- Stage 2 Pressure Injury:
- Partial-thickness skin loss involving the epidermis and presenting with an exposed, viable dermis.
- Wound bed is viable, pink or red, and moist; may also present as an intact or ruptured serum-filled fluid blister.
- Critical intervention: Absolutely do not massage or apply moisturizer in a circular motion over Stage 2 injuries or reddened skin, as mechanical shear destroys the newly developing microvasculature.
- Stage 3 Pressure Injury:
- Full-thickness tissue loss in which subcutaneous adipose (fat) tissue is directly visible.
- Slough and/or eschar may be present; granulation tissue, epibole (rolled wound edges), undermining, and sinus tract tunneling may occur.
- Does not extend into underlying fascia, muscle, tendon, ligament, or bone.
- Optimal nutritional therapy for Stage 3 healing: Meals dense in lean protein, complex carbohydrates, and vitamin C to promote tissue synthesis; example: Grilled chicken, brown rice, romaine salad, and fresh orange slices.
- Stage 4 Pressure Injury:
- Full-thickness skin and tissue loss featuring directly exposed, visible, or palpable bone, muscle, tendon, or joint capsule.
- Note on transcript phrasing: The source materials state, "STAGE 4 : Bone or muscle exposed = UNSTAGABLE", capturing both Stage 4 criteria (exposed muscle/bone) and its historical notation alongside extensive non-evaluable tissue beds.
- Unstageable Pressure Injury:
- Full-thickness tissue loss where the true base and depth of the wound bed are entirely obscured by overlying necrotic slough (yellow, tan, gray, green, or brown) or eschar (tan, brown, or black).
- Deep Tissue Pressure Injury (DTPI):
- Intact or non-intact skin displaying persistent, localized, non-blanchable deep red, maroon, or purple discoloration, or epidermal separation revealing a dark wound bed or blood-filled blister.
- Topical Precaution: Do not apply moisturizing lotions directly onto broken or ulcerated areas of any established pressure ulcer.
Mobility & Shear Reduction Protocols:
- When repositioning immobile clients in bed, manually lift them completely using transfer sheets or assistive mechanical devices; never drag or pull clients across sheets to eliminate friction and shear.
- For localized IV site complications exhibiting edema or swelling, elevate the affected extremity above the level of the heart to promote fluid drainage.
Infection Control and Transmission-Based Precautions
Contact Precautions:
- Personal Protective Equipment (PPE): Gown and gloves required prior to room entry.
- Pathogens & Conditions Requiring Contact Precautions:
- Multidrug-resistant organisms including MRSA and Vancomycin-Resistant Enterococcus (VRE).
- Clostridioides difficile (C. diff): Requires strict hand hygiene utilizing antimicrobial soap and water; alcohol-based hand sanitizers do not kill sporicidal organisms.
- Impetigo (until of antibiotic therapy completed).
- Scabies.
- Pediculosis (until initial treatment completed).
- Localized Herpes Zoster in an immunocompetent host with all active lesions completely covered.
Droplet Precautions:
- Personal Protective Equipment (PPE): Standard surgical mask required within close proximity of the client.
- Pathogens Requiring Droplet Precautions:
- Meningococcal Meningitis (Neisseria meningitidis).
- Haemophilus influenzae type B Meningitis.
- Influenza.
- Pertussis (Whooping cough).
- Streptococcal Pharyngitis.
Airborne Precautions:
- Engineering Controls & Equipment: Negative air-flow pressure isolation room with a minimum of air exchanges per hour and the door kept closed at all times; healthcare workers must wear a fit-tested particulate respirator (N95 or higher).
- Pathogens Requiring Airborne Precautions:
- Measles (Rubeola).
- Varicella-Zoster Virus (Chickenpox).
- Disseminated Herpes Zoster.
- Pulmonary Tuberculosis (TB).
- Note on transcript documentation: Contact Dermatitis is cataloged alongside Airborne Precautions (N95 and negative pressure) within specialized respiratory isolation indices.
- Protocol for Measles Management:
- The negative-pressure door must remain closed at all times.
- Healthcare personnel must remove and discard their N95 respirator only after exiting the patient's room and closing the door.
- Client transport: If transport outside the room is necessary, the client must wear a standard surgical mask.
- MMR vaccination notes: The Measles-Mumps-Rubella (MMR) vaccine is a live attenuated formulation; it is strictly contraindicated during pregnancy or in severely immunocompromised individuals.
- Exposure alert: Clients with recent direct exposure to measles or chickenpox must completely avoid taking intranasal corticosteroids, which suppress localized mucosal immune defenses.
- Protocol for Varicella (Chickenpox):
- Client remains contagious starting prior to the emergence of the cutaneous rash.
- Client requires an airborne isolation negative-pressure room with the door closed.
- In-room and transport PPE: Transcript documents that the client wears an N95 when in the room and wears a surgical mask during external transport.
Combination Airborne + Contact Precautions:
- Indication: Disseminated Herpes Zoster (shingles involving multiple dermatomes or immunocompromised host).
- Requirements: Implementation of negative air-flow pressure ventilation, N95 respirator, disposable protective gown, and clean examination gloves.
Respiratory Diagnostics, Monitoring, and Oxygen Administration
Arterial Blood Gas (ABG) Reference Ranges & Acid-Base Physiology:
- Normal Arterial Reference Parameters:
- :
- :
- :
- :
- Acid-Base Interpretation: A direct decrease in arterial partial pressure of carbon dioxide () secondary to alveolar hyperventilation results in Respiratory Alkalosis.
Clinical Manifestations of Hypoxemia:
- Earliest objective sign: Subtle change in the baseline respiratory rate or breathing pattern.
- Neurocognitive deterioration progression: Mild restlessness, impaired judgment, and agitation, progressing to active confusion, profound lethargy, and terminal coma.
Oxygen Delivery Devices & FiO2 Parameters:
- Nasal Cannula:
- Flow rate: Delivered at .
- Delivered Fraction of Inspired Oxygen (): Approximately .
- Rule of thumb: Every additional increases by approximately .
- Postoperative hypoxia: Initial oxygen device applied to a postoperative client demonstrating low oxygen saturation.
- Simple Face Mask:
- Flow rate: Delivered at .
- Safety imperative: Requires a minimum flow rate of at least to flush accumulated carbon dioxide () out of the mask and prevent rebreathing.
- Delivered : Approximately .
- Partial Rebreather Mask:
- Flow rate: Delivered at .
- Delivered : Approximately .
- Non-Rebreather Mask (NRB):
- Flow rate: Delivered at .
- Reservoir management: Oxygen flow must be calibrated so the reservoir bag remains at least two-thirds full during both inspiration and expiration.
- Delivered : Provides , representing the highest concentration of non-invasive oxygen delivered without endotracheal intubation.
- Venturi Mask:
- Flow rate: Variable flow governed by precise color-coded entrainment adaptors.
- Delivered : Delivers an exact, fixed concentration between .
- Clinical indication: Gold standard oxygen device for clients with Chronic Obstructive Pulmonary Disease (COPD), as it prevents inadvertent high-concentration oxygen delivery that blunts the hypoxic drive.
Oxygen Toxicity & Clinical Precautions:
- Signs of High-Flow Oxygen Toxicity: Dyspnea, persistent nonproductive cough, retrosternal chest pain, restlessness, and paresthesias (tingling sensations in hands and feet). These signs require immediate notification of the provider.
- COPD Precautions: Monitor clients with chronic hypercapnia closely for narcosis manifested as progressive somnolence and drowsiness. However, never withhold supplemental oxygen from a profoundly hypoxic COPD client out of fear of suppressing their hypoxic respiratory drive; titrate to target saturation and continuously reassess.
- Differential Diagnosis Alert: A cherry-red coloration of the mucous membranes is the classic clinical manifestation of Carbon Monoxide Poisoning, not oxygen toxicity.
Diagnostic Sputum Specimen Collection:
- Timing: Collect the sample first thing in the morning upon awakening, prior to eating or drinking.
- Antimicrobial Timing: Collect all sputum and blood specimens prior to initiating the first dose of antimicrobial therapy.
- Procedure: Have the client thoroughly rinse their mouth with water to eliminate food debris; instruct the client to take deep breaths and produce a deep cough originating from the lower lungs (saliva or postnasal drainage is invalid).
- Specimen Handling: Collect into a sterile container without touching the interior walls or lid; deliver immediately to the laboratory. If delivery is delayed, the specimen must be discarded and recollected.
- Tuberculosis (Acid-Fast Bacilli / AFB) Protocol: Obtain separate consecutive sputum specimens on separate days, preferably collected in the early morning.
Incentive Spirometry:
- Instructional Steps: Instruct the client to exhale completely, seal their lips tightly around the mouthpiece, and perform a slow, sustained deep inhalation; hold the breath for at peak inspiration, then exhale slowly. The client must never blow into the spirometer.
- Frequency: Perform deep breaths every hour while awake.
- Post-Procedure: The client must perform a deep cough following each set of breaths to effectively mobilize pulmonary secretions.
Acute and Chronic Respiratory Conditions
Asthma:
- Pathophysiology: Chronic inflammatory airway disorder marked by bronchial hyperresponsiveness, mucosal edema, and bronchospasm.
- Auscultation Red Flag ("Silent Chest"): A client experiencing an acute asthma exacerbation who presents with sudden cessation or reduction of audible wheezing without concurrent normalization of oxygen saturation indicates severe terminal airway constriction and impending acute respiratory failure; immediate emergency intervention is required.
- Acute Attack Interventions:
- Elevate client to High Fowler's position.
- Administer high-flow humidified supplemental oxygen.
- Inhale short-acting beta-2 adrenergic agonists (SABA; Albuterol).
- Always utilize a spacer with a Metered-Dose Inhaler (MDI) to decelerate the aerosol plume, optimize drug transit, and increase deep pulmonary deposition.
- Peak Flow Monitoring Zones:
- Green Zone: of personal best; signals good control, maintain routine maintenance regimen.
- Yellow Zone: of personal best; signals caution or impending flare, administer short-acting rescue bronchodilator.
- Red Zone: of personal best; signals a medical emergency, immediately administer rescue medications and access emergent medical assistance.
- Priority teaching point: The cornerstone of asthma self-management is determining the client's individual "personal best" peak flow value.
- Pharmacological Cautions & Triggers: Strictly avoid Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) due to their inhibition of the arachidonic acid cyclooxygenase pathway, which shifts metabolism toward leukotrienes and triggers lethal bronchospasm.
Pharmacologic Delivery & Dual-Inhaler Sequence:
- Dual Inhaler Order:
- Administer the fast-acting bronchodilator (Albuterol) first to dilate constricted bronchioles.
- Wait .
- Administer the long-term anti-inflammatory corticosteroid inhaler second, ensuring the opened bronchial tree permits the steroid to penetrate deeply into peripheral alveoli.
- Inhaled Corticosteroid Side Effects & Prevention:
- Localized complications: Oral candidiasis (thrush) and hoarseness (dysphonia).
- Prevention: Use an MDI spacer device and vigorously rinse the mouth and gargle with water following every administration, spitting out the rinse.
- Corticosteroid Overuse Complications: Chronic high-dose use causes dermal thinning, easy ecchymosis/bruising, progressive osteoporosis, hyperglycemia, and systemic immunosuppression.
- Mini-Nebulizer Administration: Teach the client to utilize diaphragmatic breathing patterns during therapy. Priority educational element is equipment sanitation: nebulizer cups and mouthpieces must be thoroughly rinsed after every treatment and air-dried; dirty equipment rapidly colonizes bacteria that are aerosolized directly into lung parenchyma.
Status Asthmaticus:
- Definition: A severe, life-threatening asthma exacerbation that fails to respond to intensive standard therapy (repeated bronchodilators and systemic steroids).
- Critical Interventions: Endotracheal intubation with mechanical ventilatory support and immediate intravenous fluid resuscitation.
Obstructive Sleep Apnea (OSA):
- Etiology & Risk Factors: Upper airway collapse during sleep resulting in recurrent apnea and hypopnea; primary risk factor is obesity.
- Expected Clinical Findings: Loud nocturnal snoring, excessive daytime somnolence, witnessed apneic episodes, and early morning headaches resulting from overnight carbon dioxide retention.
- Atypical/Non-OSA Findings: Fever, dry nonproductive cough, diminished vesicular breath sounds, and dysphonia are indicative of infectious or parenchymal processes, not uncomplicated OSA.
- First-Line Treatment: Continuous Positive Airway Pressure (CPAP) during sleep.
Infectious Respiratory Conditions:
- Common Cold (Acute Viral Rhinitis):
- Etiology: Rhinovirus is the primary causative pathogen.
- Viral dynamics: Highly infectious pathogen that sheds prior to clinical symptom onset; viral communicability peaks within the first .
- Pharmacological cautions: Oral sympathomimetic decongestants cause systemic vasoconstriction; use with extreme caution in clients with hypertension, cardiac disease, angle-closure glaucoma, and benign prostatic hyperplasia (BPH).
- Topical nasal decongestants: Restrict usage to no more than ; extended administration produces severe rebound nasal congestion (rhinitis medicamentosa).
- Influenza:
- Infection control: Droplet Precautions.
- Immunization: Annual influenza vaccination is indicated for all individuals aged ; vaccine formulations are modified annually to counter antigenic shifts and drifts.
- Pediatric safety warning: Never administer Aspirin or salicylate compounds to children or adolescents presenting with viral symptoms due to the risk of Reye syndrome; utilize acetaminophen for pyrexia.
- High-Risk Cohorts for Fatal Influenza Complications:
- Older adults aged years and older.
- Pediatric clients under years (highest vulnerability under years).
- Pregnant clients and postpartum individuals up to post-delivery.
- Clients with chronic medical morbidities: Cardiovascular disease, pulmonary disease (asthma, COPD), diabetes mellitus, renal or hepatic disorders, and severe obesity ().
- Immunosuppressed hosts and residents of long-term care facilities.
- Highest statistical vulnerability: A -year-old client with an active clinical history of cardiac disease or diabetes.
- Primary complication: Secondary bacterial pneumonia or primary viral pneumonia.
- Chronic Rhinitis & Sinusitis:
- Critical red flag: The sudden emergence of nuchal rigidity (neck stiffness) in a client with chronic rhinosinusitis signifies the direct intracranial extension of infection into the meninges (Bacterial Meningitis).
- Manifestations of meningitis: Severe headache, high fever, nuchal rigidity, photophobia, altered mentation, positive Kernig's and Brudzinski's signs, and petechial purpuric rash.
- Other sinusitis complications: Orbital cellulitis (periorbital edema, impaired extraocular motility, visual changes) and intracerebral abscess formation.
- Acute Pharyngitis:
- Dietary regimen: Soft, bland nutrition (mashed potatoes, puddings) and soothing cool liquids; push oral fluid intake to ; avoid spicy, acidic, or extremely hot foodstuffs.
- Pharmacotherapy: Erythromycin (macrolide class) represents the first-line alternative for individuals with a confirmed penicillin allergy.
- Erythromycin toxicities: Gastrointestinal distress (cramping, diarrhea) and cardiac QT-interval prolongation.
- Client education: Emphasize completing the entire prescribed antimicrobial regimen.
- Laryngitis:
- Care: Strict avoidance of tobacco smoking until laryngeal mucosal inflammation resolves; inhalation of cool steam or cold aerosols; antibiotics indicated only when bacterial infection is documented.
- Voice rest: Maintain strict voice rest by utilizing written communication; instruct the client that whispering places severe mechanical strain on the vocal cords.
- Danger signs: Hoarseness lasting longer than despite absolute voice rest (highly suspicious for laryngeal carcinoma), hemoptysis (coughing up blood), stridor (noisy respiratory breathing), and severe dysphagia rendering the client unable to swallow saliva.
- Geriatric considerations: Laryngitis carries heightened severity in older adults; monitor closely for the secondary development of pneumonia.
Acute Cardiopulmonary Crises:
- Acute Pulmonary Edema:
- A client presenting with sudden dyspnea and shortness of breath warrants immediate administration of high-flow oxygen and a beta-2 agonist.
- Nursing assessment: Ask the client, "Did you have any coughing before you became short of breath?" Coughing prior to dyspnea differentiates etiologies pointing toward mucus plugging, mechanical aspiration, or acute infection.
- Priority step-by-step nursing actions: Elevate head of bed immediately to High Fowler's position Measure pulse oximetry () Assess respiratory rate Auscultate bilateral lung sounds.
- Pulmonary Embolism (PE):
- Any client displaying the abrupt onset of dyspnea coupled with tachycardia or pleuritic chest pain, particularly after prolonged immobility or surgical bedrest, must be evaluated immediately for a pulmonary embolism.
Airway Clearance, Suctioning, and Tracheostomy Care
Tracheostomy & Endotracheal Suctioning Protocols:
- Pre-Procedure Preparation:
- Confirm that suction apparatus is functional; connect sterile suction catheter.
- Pre-oxygenate (hyperoxygenate) the client with prior to catheter insertion.
- Insertion & Suction Mechanics:
- Insert the suction catheter gently into the artificial airway without applying suction until resistance is met or the client coughs.
- Apply negative suction pressure exclusively while rotating and withdrawing the catheter.
- Limit active suction duration to a maximum of per pass to prevent profound hypoxemia.
- Passes & Recovery Intervals:
- Allow the client to fully recover between passes (protocol documents resting between passes, while ensuring adequate re-oxygenation).
- Strictly perform no more than suction passes during a single clinical suctioning session.
- Unnecessary, excessive suctioning must be avoided as it induces severe mucosal ulceration and reflex bronchospasm.
- Anatomical Order of Suctioning: Always suction the sterile tracheostomy airway first before suctioning the contaminated oral cavity (suction trach before mouth).
- Absolute Indications to Abort Suctioning: Immediately discontinue suctioning, withdraw the catheter, and hyperoxygenate the client with if the client develops acute bradycardia, cardiac dysrhythmias, or precipitous desaturation ( drop).
- Evaluating Suctioning Efficacy: Assess pulse oximetry () and auscultate lung fields for cleared breath sounds.
Comprehensive Tracheostomy Airway Management:
- Humidification Mandate: Because an artificial tracheostomy airway entirely bypasses the anatomical upper airway (nasopharynx), supplemental oxygen must always be delivered warmed and thoroughly humidified to prevent thick mucous plug formation.
- Aspiration Risk: Tracheostomy alterations impair the normal swallowing reflex and weaken cough mechanics, elevating the risk for pulmonary aspiration.
- Pharmacological Precaution: Exercise extreme vigilance with opioid analgesics and central nervous system sedatives, as they depress the protective cough reflex and blunt respiratory drive.
- Therapeutic Positioning for Dyspnea:
- Position the dyspneic client in a High Fowler's position or the Tripod position (sitting up and leaning forward supported over an overbed table).
- Unilateral lung disease: Position the client with the unaffected, healthy lung dependent ("good lung down") to optimize gravitational blood flow, perfusion, and ventilation-perfusion matching.